Back

Correlation of OCT-Based Radiomic Signatures With Dose-Associated Radiation Response in Tumor Spheroids

Arndt, M. D.; Hansler, R.; Tirinato, L.; Tkachenko, A.; Seco, J.; Schepers, U.; Spadea, M. F.

2026-07-09 cancer biology
10.64898/2026.07.08.737210 bioRxiv
Show abstract

Background: Three-dimensional tumor spheroids are an established radiobiology model, but scalable, reproducible readouts of dose-dependent radiation response are lacking. We evaluated whether optical coherence tomography (OCT) radiomics can quantify dose-associated response in spheroids, and how it compares with conventional brightfield morphology. Methods: This in vitro, cross-sectional study used SAS oral squamous cell carcinoma spheroids seeded at two densities (5000 and 10000 cells), irradiated at 0 to 12 Gy, and imaged on days 1 to 11 post-irradiation. Each OCT acquisition yielded co-registered structural-intensity and speckle-variance volumes. Radiomic features (shape, first-order, texture) were extracted with Radiomics.jl, filtered for repeatability, correlation-pruned, and ensemble-ranked. Dose correlation was assessed by repeated 5-fold cross-validation across five regressors, comparing brightfield-only (BF), OCT-only, and combined OCT+BF feature sets with paired Wilcoxon tests. Results: OCT-only models consistently outperformed the BF baseline (median R2 0.77 to 0.85 versus 0.61 to 0.69; p<0.001 for all regressors). Adding brightfield to OCT gave no consistent benefit, reaching significance only for Random Forest (p=0.026, power 0.62). A compact shared feature subset combined brightfield area dynamics with OCT texture, shape, and speckle-variance descriptors, all showing low repeat-scan variability relative to cohort variability. Conclusions: OCT radiomics provides a sensitive, reproducible, label-free high-throughput readout of spheroid radiation dose response that outperforms the current brightfield-based approach, without requiring concurrent brightfield acquisition.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Radiotherapy and Oncology
19 papers in training set
Top 0.1%
23.2%
2
International Journal of Radiation Oncology*Biology*Physics
25 papers in training set
Top 0.1%
19.2%
3
Scientific Reports
3612 papers in training set
Top 6%
8.2%
50% of probability mass above
4
Medical Physics
14 papers in training set
Top 0.1%
7.0%
5
Physics in Medicine & Biology
18 papers in training set
Top 0.1%
5.4%
6
JCO Clinical Cancer Informatics
22 papers in training set
Top 0.2%
3.4%
7
Nature Communications
5641 papers in training set
Top 39%
2.5%
8
Cancers
213 papers in training set
Top 2%
2.5%
9
Cancer Research Communications
51 papers in training set
Top 0.6%
2.2%
10
PLOS ONE
5266 papers in training set
Top 47%
1.8%
11
Molecular Cancer Therapeutics
40 papers in training set
Top 0.5%
1.8%
12
Frontiers in Oncology
103 papers in training set
Top 2%
1.2%
13
Clinical Cancer Research
64 papers in training set
Top 1%
1.2%
14
npj Precision Oncology
53 papers in training set
Top 1%
1.1%
15
Clinical and Translational Radiation Oncology
10 papers in training set
Top 0.2%
1.1%
16
BMC Cancer
67 papers in training set
Top 2%
1.0%
17
Communications Biology
993 papers in training set
Top 28%
0.9%
18
JID Innovations
11 papers in training set
Top 0.2%
0.9%
19
Genome Medicine
183 papers in training set
Top 6%
0.6%
20
PLOS Computational Biology
1863 papers in training set
Top 21%
0.6%
21
Cancer Research
130 papers in training set
Top 3%
0.6%
22
British Journal of Cancer
49 papers in training set
Top 2%
0.6%
23
International Journal of Cancer
49 papers in training set
Top 1%
0.6%
24
npj Imaging
12 papers in training set
Top 0.3%
0.6%
25
Science Advances
1243 papers in training set
Top 35%
0.5%
26
Neuro-Oncology
36 papers in training set
Top 0.7%
0.5%
27
eLife
5828 papers in training set
Top 71%
0.5%